IQVIA Delivers Strong Q4 and Full-Year 2024 Results, Reaffirms 2025 Guidance Amid Continued Growth IQVIA Reports Holdings a global leader in clinical research services, commercial insights, and healthcare intelligence for…
Health Collaborates Axena Health Partners with Mayo Clinic to Revolutionize Female Pelvic Health Education and Treatment Health Collaborates Axena Health a pioneering medical device company specializing in female pelvic health,…
Health Reports Gozio Health Achieves Unprecedented Growth in 2024: A Mobile Health Revolution Health Reports Gozio Health, a pioneering provider of location-aware mobile Health Reports health platforms, has announced remarkable…
Ruth K. Bash Inspira Health Elevates Ruth K. Bash to Senior Vice President and Chief Experience Officer Ruth K. Bash Inspira Health has announced the promotion of Ruth K. Bash,…
Press Ganey Teams Up with Microsoft to Revolutionize the Healthcare Experience Healthcare Experience Press Ganey, the leading provider of experience measurement, data analytics, and insights for health systems and health…
Understanding Cell and Gene Therapy Trials for Pediatric Rare Diseases: Join the Upcoming Xtalks Webinar Cell and gene therapy (CGT) has emerged as a promising treatment for rare diseases, particularly…
Genvax Technologies Receives Series Seed Plus Funding to Revolutionize Vaccine Development for Animal Health Genvax Technologies, a pioneering startup in the field of RNA vaccine development for animal health, has…
Dxcover Secures $6.2 Million in Funding to Drive Growth and Expand Cancer Diagnostics Reach Dxcover Limited, a pioneering clinical-stage diagnostics company known for its cutting-edge multiomic spectral analysis technology (MOSA-Dx™)…
AliveDx has announced the receipt of IVDR-CE mark for its MosaiQ AiPlex® CTDplus multiplex assay, a significant advancement in the diagnosis and management of Systemic Autoimmune Rheumatic Diseases (SARDs). This…
Cigna Group Reports Strong 2024 Financial Results, Sets 2025 Outlook, and Announces Dividend Increase Global health company The Cigna Group (NYSE: CI) has released its financial results for the fourth…
Takeda (TOKYO:4502/NYSE:TAK) has announced its third-quarter earnings results for fiscal year 2024, reporting significant progress in its Growth & Launch Products. These products experienced robust growth, posting a 14.6% increase…
Congress Spotlight: Merz Aesthetics® Unveils Ultherapy PRIME® at 2025 IMCAS Merz Aesthetics is launching Ultherapy PRIME® across Europe, the Middle East, and Africa, marking an exciting evolution of the non-invasive…